220 related articles for article (PubMed ID: 36189795)
1. Increased core body temperature exacerbates defective protein prenylation in mouse models of mevalonate kinase deficiency.
Munoz MA; Skinner OP; Masle-Farquhar E; Jurczyluk J; Xiao Y; Fletcher EK; Kristianto E; Hodson MP; O'Donoghue SI; Kaur S; Brink R; Zahra DG; Deenick EK; Perry KA; Robertson AA; Mehr S; Hissaria P; Mulders-Manders CM; Simon A; Rogers MJ
J Clin Invest; 2022 Oct; 132(19):. PubMed ID: 36189795
[TBL] [Abstract][Full Text] [Related]
2. Defective Protein Prenylation in a Spectrum of Patients With Mevalonate Kinase Deficiency.
Munoz MA; Jurczyluk J; Simon A; Hissaria P; Arts RJW; Coman D; Boros C; Mehr S; Rogers MJ
Front Immunol; 2019; 10():1900. PubMed ID: 31474985
[TBL] [Abstract][Full Text] [Related]
3. Lack of Prenylated Proteins, Autophagy Impairment and Apoptosis in SH-SY5Y Neuronal Cell Model of Mevalonate Kinase Deficiency.
Tricarico PM; Romeo A; Gratton R; Crovella S; Celsi F
Cell Physiol Biochem; 2017; 41(4):1649-1660. PubMed ID: 28359055
[TBL] [Abstract][Full Text] [Related]
4. Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency.
Politiek FA; Waterham HR
Front Immunol; 2021; 12():724991. PubMed ID: 34539662
[TBL] [Abstract][Full Text] [Related]
5. Mevalonate kinase deficiency leads to decreased prenylation of Rab GTPases.
Jurczyluk J; Munoz MA; Skinner OP; Chai RC; Ali N; Palendira U; Quinn JM; Preston A; Tangye SG; Brown AJ; Argent E; Ziegler JB; Mehr S; Rogers MJ
Immunol Cell Biol; 2016 Nov; 94(10):994-999. PubMed ID: 27377765
[TBL] [Abstract][Full Text] [Related]
6. Temperature and drug treatments in mevalonate kinase deficiency: an ex vivo study.
Tricarico PM; Kleiner G; Piscianz E; Zanin V; Monasta L; Crovella S; Marcuzzi A
Biomed Res Int; 2013; 2013():715465. PubMed ID: 24073415
[TBL] [Abstract][Full Text] [Related]
7. Mevalonate kinase-deficient THP-1 cells show a disease-characteristic pro-inflammatory phenotype.
Politiek FA; Turkenburg M; Ofman R; Waterham HR
Front Immunol; 2024; 15():1379220. PubMed ID: 38550596
[TBL] [Abstract][Full Text] [Related]
8. Mevalonate Pathway Blockade, Mitochondrial Dysfunction and Autophagy: A Possible Link.
Tricarico PM; Crovella S; Celsi F
Int J Mol Sci; 2015 Jul; 16(7):16067-84. PubMed ID: 26184189
[TBL] [Abstract][Full Text] [Related]
9. Vasculitis in a patient with mevalonate kinase deficiency (MKD): a case report.
Omoyinmi E; Rowczenio D; Sebire N; Brogan PA; Eleftheriou D
Pediatr Rheumatol Online J; 2021 Nov; 19(1):161. PubMed ID: 34809655
[TBL] [Abstract][Full Text] [Related]
10. Molecular and cellular consequences of mevalonate kinase deficiency.
Politiek FA; Turkenburg M; Henneman L; Ofman R; Waterham HR
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167177. PubMed ID: 38636615
[TBL] [Abstract][Full Text] [Related]
11. Mevalonate kinase deficiency, a metabolic autoinflammatory disease.
van der Burgh R; Ter Haar NM; Boes ML; Frenkel J
Clin Immunol; 2013 Jun; 147(3):197-206. PubMed ID: 23110805
[TBL] [Abstract][Full Text] [Related]
12. The inhibition of mevalonate pathway induces upregulation of NALP3 expression: new insight in the pathogenesis of mevalonate kinase deficiency.
Pontillo A; Paoluzzi E; Crovella S
Eur J Hum Genet; 2010 Jul; 18(7):844-7. PubMed ID: 20179743
[TBL] [Abstract][Full Text] [Related]
13. 25-Hydroxycholesterol and inflammation in Lovastatin-deregulated mevalonate pathway.
Tricarico PM; Gratton R; Braga L; Celsi F; Crovella S
Int J Biochem Cell Biol; 2017 Nov; 92():26-33. PubMed ID: 28918367
[TBL] [Abstract][Full Text] [Related]
14. Repositioning of Tak-475 In Mevalonate Kinase Disease: Translating Theory Into Practice.
Marcuzzi A; Loganes C; Celeghini C; Kleiner G
Curr Med Chem; 2018; 25(24):2783-2796. PubMed ID: 28901277
[TBL] [Abstract][Full Text] [Related]
15. Unprenylated RhoA contributes to IL-1β hypersecretion in mevalonate kinase deficiency model through stimulation of Rac1 activity.
van der Burgh R; Pervolaraki K; Turkenburg M; Waterham HR; Frenkel J; Boes M
J Biol Chem; 2014 Oct; 289(40):27757-65. PubMed ID: 25107911
[TBL] [Abstract][Full Text] [Related]
16. [A 6-year-old girl diagnosed with mevalonate kinase deficiency who had hydrops fetalis and neonatal-onset cholestasis].
Yamashita Y; Matsumoto S; Hiramoto R; Komori I; Tanaka T; Nishikomori R; Heike T; Umetsu S; Inui A
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(2):131-137. PubMed ID: 28603204
[TBL] [Abstract][Full Text] [Related]
17. Defective protein prenylation is a diagnostic biomarker of mevalonate kinase deficiency.
Munoz MA; Jurczyluk J; Mehr S; Chai RC; Arts RJW; Sheu A; McMahon C; Center JR; Singh-Grewal D; Chaitow J; Campbell DE; Quinn JMW; Alexandrov K; Tnimov Z; Tangye SG; Simon A; Phan TG; Rogers MJ
J Allergy Clin Immunol; 2017 Sep; 140(3):873-875.e6. PubMed ID: 28501347
[No Abstract] [Full Text] [Related]
18. Identification of FDA-approved drugs that increase mevalonate kinase in hyper IgD syndrome.
Politiek FA; Turkenburg M; Koster J; Ofman R; Waterham HR
J Inherit Metab Dis; 2024 Mar; 47(2):302-316. PubMed ID: 38131282
[TBL] [Abstract][Full Text] [Related]
19. Quantification of mevalonate-5-phosphate using UPLC-MS/MS for determination of mevalonate kinase activity.
Reitzle L; Maier B; Stojanov S; Teupser D; Muntau AC; Vogeser M; Gersting SW
Clin Biochem; 2015 Aug; 48(12):781-7. PubMed ID: 25982894
[TBL] [Abstract][Full Text] [Related]
20. [Mevalonate kinase deficiency].
Galeotti C
Rev Prat; 2023 Oct; 73(8):850-854. PubMed ID: 38354005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
